You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Chula Vista (1)

Edinburg (1)

Georgetown (1)

High Point (1)

Miami (1)

Renton (1)

Rialto (1)

San Antonio (1)

Condition

Diabetes Mellitus, Type 2 (2)

NON-ALCOHOLIC STEATOHEPATITIS (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Dong-A ST Co., Ltd. (2)

NeuroBo Pharmaceuticals Inc. (1)

Collaborator

Intervention

da-1241 (3)

placebo (2)

sitagliptin (2)

da-1241 placebo (1)

metformin (1)

sitagliptin placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

da-1241

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

Recruiting

NON-ALCOHOLIC STEATOHEPATITIS

DA-1241
+3 more

Rialto, California
+5 more

Sep 19, 2023

Diabetes, Type 2 Trial in United States (DA-1241, Placebo, Sitagliptin)

Completed

Diabetes Mellitus, Type 2

DA-1241
+2 more

Chula Vista, California
+3 more

Feb 9, 2021

Diabetes, Type 2 Trial in Baltimore (Placebo, Metformin, DA-1241)

Completed

Diabetes Mellitus, Type 2

Placebo
+2 more

Baltimore, Maryland

Early Phase Clinical Unit

Nov 16, 2017